Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologics
More oncology biologics are becoming available for subcutaneous (sc.) administration and
are expected to provide useful therapeutic options. We evaluated evidence published in the …
are expected to provide useful therapeutic options. We evaluated evidence published in the …
A systematic review of time and resource use costs of subcutaneous versus intravenous administration of oncology biologics in a hospital setting
C McCloskey, MT Ortega, S Nair, MJ Garcia… - PharmacoEconomics …, 2023 - Springer
Background The introduction of human epidermal growth factor receptor 2 (HER2)-targeted
treatment options, including dual HER2 blockade, has improved the prognosis for patients …
treatment options, including dual HER2 blockade, has improved the prognosis for patients …
Subcutaneous trastuzumab: a review in HER2-positive breast cancer
YA Heo, YY Syed - Targeted Oncology, 2019 - Springer
A subcutaneous (SC) formulation of trastuzumab, a potent humanized anti-Human
Epidermal growth factor Receptor 2 (HER2) receptor monoclonal antibody, with a …
Epidermal growth factor Receptor 2 (HER2) receptor monoclonal antibody, with a …